High Tower Advisors, LLC Neogenomics Inc Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 23,967 shares of NEO stock, worth $297,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,967
Previous 26,747
10.39%
Holding current value
$297,430
Previous $394,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$244 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$177 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$81 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$76.5 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$76.4 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.56B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...